Related Experiment Videos
Current perspectives on immunotherapy for colorectal cancer
C A Maxwell-Armstrong1, J H Scholefield
1Department of Surgery, Queens Medical Centre, Nottingham, UK.
Drugs of Today (Barcelona, Spain : 1998)
|July 25, 2003
Summary
Colorectal cancer immunotherapy explores various strategies to boost the immune system against cancer. These approaches include stimulating the whole immune system, using specific antibodies, or targeting cancer cells directly with vaccines.
Area of Science:
- Oncology
- Immunology
Background:
- Colorectal cancer immunotherapy is being investigated as an adjuvant treatment.
- Several distinct immunotherapy approaches are under study.
Purpose of the Study:
- To review the different types of immunotherapies for colorectal cancer.
- To outline the mechanisms of action for each approach.
Main Methods:
- Review of active nonspecific immunotherapy.
- Review of adoptive immunotherapy.
- Review of monoclonal antibodies.
- Review of active specific immunotherapy, including vaccines and viral vectors.
Main Results:
- Active nonspecific immunotherapy stimulates the general immune system.
- Adoptive immunotherapy involves ex vivo stimulated lymphocytes.
- Monoclonal antibodies target tumor-associated antigens (TAAs) to induce cell death.
- Active specific immunotherapy encompasses diverse methods like peptide vaccines, DNA/RNA vaccines, and viral vectors to target cancer cells.
Conclusions:
- Colorectal cancer immunotherapy presents a diverse range of strategies.
- These methods aim to leverage the immune system to combat colorectal cancer effectively.